Literature DB >> 11740489

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.

Thomas G Hofmann1, Andreas Möller, Hüaeyin Sirma, Hanswalter Zentgraf, Yoichi Taya, Wulf Dröge, Hans Will, M Lienhard Schmitz.   

Abstract

Transcriptional activity of p53, a central regulatory switch in a network controlling cell proliferation and apoptosis, is modulated by protein stability and post-translational modifications including phosphorylation and acetylation. Here we demonstrate that the human serine/threonine kinase homeodomain-interacting protein kinase-2 (HIPK2) colocalizes and interacts with p53 and CREB-binding protein (CBP) within promyelocytic leukaemia (PML) nuclear bodies. HIPK2 is activated by ultraviolet (UV) radiation and selectively phosphorylates p53 at Ser 46, thus facilitating the CBP-mediated acetylation of p53 at Lys 382, and promoting p53-dependent gene expression. Accordingly, the kinase function of HIPK2 mediates the increased expression of p53 target genes, which results in growth arrest and the enhancement of UV-induced apoptosis. Interference with HIPK2 expression by antisense oligonucleotides impairs UV-induced apoptosis. Our results imply that HIPK2 is a novel regulator of p53 effector functions involved in cell growth, proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11740489     DOI: 10.1038/ncb715

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  204 in total

1.  Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.

Authors:  Isabelle Soubeyran; Isabelle Mahouche; Aude Grigoletto; Thierry Leste-Lasserre; Guillaume Drutel; Christophe Rey; Stephane Pedeboscq; France Blanchard; Veronique Brouste; Jean-Christophe Sabourin; Yves Bécouarn; Josy Reiffers; François Ichas; Francesca De Giorgi
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Phosphoregulators: protein kinases and protein phosphatases of mouse.

Authors:  Alistair R R Forrest; Timothy Ravasi; Darrin Taylor; Thomas Huber; David A Hume; Sean Grimmond
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

3.  Human cytomegalovirus UL97 kinase prevents the deposition of mutant protein aggregates in cellular models of Huntington's disease and ataxia.

Authors:  Cristy Tower; Lianwu Fu; Rachel Gill; Mark Prichard; Mathieu Lesort; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

Review 4.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

5.  Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family.

Authors:  Qin He; Jingxue Shi; Hong Sun; Jie An; Ying Huang; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2010

Review 6.  The DNA damage-induced cell death response: a roadmap to kill cancer cells.

Authors:  Sonja Matt; Thomas G Hofmann
Journal:  Cell Mol Life Sci       Date:  2016-01-20       Impact factor: 9.261

7.  Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.

Authors:  Y Akaike; Y Kuwano; K Nishida; K Kurokawa; K Kajita; S Kano; K Masuda; K Rokutan
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

Review 8.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

9.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

Review 10.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.